Clinical trial · Observational
Cyberknife Radiosurgery and Quality of Life
NCT01163539CI-TRIAL-00022798terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to look at pain control and QOL improvement after treatment with CK Radiosurgery for spinal metastases.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bone Cancer | Malignant Bone Neoplasm | ALIAS | 0.90 |
| Central Nervous System Cancer | Malignant Central Nervous System Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with a spinal metastasis who will be treated with Cyberknife radiosurgery. * There are no age or gender restrictions. * There are no life expectancy restrictions. * Karnofsky Performance Status greater than 40. * Negative pregnancy test or clinically assessed as not pregnant. * Ability to understand and the willingness to sign a written informed consent document. Exclusion Criteria: * Patients with benign tumors will not be included (neurofibromas, schwannomas, etc.) * Other investigational medications or treatments will be noted, but will not preclude inclusion. * Pregnant or nursing patients will be not be included in the study due to radiation exposure.
References
Publications (0)
Data not yet available
No reference posted for this study.